Hefei Tg Immunopharma Co., Ltd.

This early-phase study tests a new drug called TGI-5, either alone or combined with the immunotherapy nivolumab, in people with advanced solid tumors (colorectal, melanoma, liver, or lung cancer) that cannot be removed by surgery. The main goals are to check safety and find the r…